Effects of Xueshuantong combined with Aspirin in treatment of patients with acute cerebral infarction
Objective:To observe effects of Xueshuantong combined with Aspirin in treatment of patients with acute cerebral infarction(ACI).Methods:A prospective study was conducted on 70 patients with ACI admitted to the hospital from January 2022 to December 2023.They were divided into control group and observation group by using the random number table method,35 cases in each group.The control group was treated with Aspirin,while the observation group was treated with Xueshuantong on the basis of that of the control group.The scores of TCM syndromes,the neurological deficits[National Institutes of Health stroke scale(NIHSS)]score,and the levels of inflammatory factors[interleukin-6(IL-6),high-sensitivity C-reactive protein(hs-CRP)]and hemorheological indexes[plasma fibrinogen(FIB),plasma viscosity(PV),whole blood high shear viscosity(HBV)]were compared between the two groups before and after the treatment.Results:After the treatment,the scores of TCM syndromes and NIHSS in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Further,after the treatment,the levels of IL-6,hs-CRP,FIB,PV and HBV in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusions:Xueshuantong combined with Aspirin in the treatment of the ACI patients can reduce the TCM syndrome scores,the NIHSS scores,the inflammatory factor levels and the hemorheology index levels.Moreover,it is superior to simple Aspirin treatment.
万方数据
维普
